Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.

Journal of translational medicine - 24 May 2013

García-González Paulina, Morales Rodrigo, Hoyos Lorena, Maggi Jaxaira, Campos Javier, Pesce Bárbara, Gárate David, Larrondo Milton, González Rodrigo, Soto Lilian, Ramos Verónica, Tobar Pía, Molina María Carmen, Pino-Lagos Karina, Catalán Diego, Aguillón Juan Carlos

Abstract excerpt

BACKGROUND: Generation of tolerogenic dendritic cells (TolDCs) for therapy is challenging due to its implications for the design of protocols suitable for clinical applications, which means not only using safe products, but also working at defining specific biomarkers for TolDCs identification, d...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autoimmunity
Share to CD4-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chemokines

Share to Dendritic Cells

Share to Dexamethasone

Share to Lipid A

Share to Receptors, CCR7

Share to Receptors, CXCR4

Source

Open in PubMed Open full text

Identifiers

PMID: 23706017
DOI: 10.1186/1479-5876-11-128
PMCID: PMC3674980

Genes

CCL19
CCR7
CXCL12
CXCR4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23706017-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines.PMID 23706017Read ↗

Comparative study of clinical grade human tolerogenic dendritic cells.Semantic proximity Read ↗

LPS activation is required for migratory activity and antigen presentation by tolerogenic dendritic cells.Semantic proximity Read ↗

Handbook of experimental pharmacology "dendritic cells": the use of dexamethasone in the induction of tolerogenic DCs.Semantic proximity Read ↗

Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.Semantic proximity Read ↗

IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction--a comparative study of human clinical-applicable DC.Semantic proximity Read ↗

Phenotypical and functional characterization of clinical-grade dendritic cells.Semantic proximity Read ↗

Gram-negative enterobacteria induce tolerogenic maturation in dexamethasone conditioned dendritic cells.Semantic proximity Read ↗

Fast generation of dendritic cells.Semantic proximity Read ↗

Poly I: C-activated dendritic cells that were generated in CellGro for use in cancer immunotherapy trials.Semantic proximity Read ↗

OM-197-MP-AC adjuvant properties: the in vitro maturation of normal and leukemic dendritic cells in a serum-free culture model.Semantic proximity Read ↗

Transcriptomic Analysis Identifies A Tolerogenic Dendritic Cell Signature.Semantic proximity Read ↗

Feeder-free generation of functional dendritic cells from human pluripotent stem cellsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.